Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 200

The DOI matches its Crossref record.

Grading and disease management in national screening for diabetic retinopathy in England and Wales

Harding, S., Greenwood, R., Aldington, S., Gibson, J., Owens, D., Taylor, R., Kohner, E., Scanlon, P., Leese, G., The Diabetic Retinopathy Grading and Disease Management Working Party · 2003 · Diabetic Medicine

Abstract

Aims A National Screening Programme for diabetic eye disease in the UK is in development. We propose a grading and early disease management protocol to detect sight‐threatening diabetic retinopathy and any retinopathy, which will allow precise quality assurance at all steps while minimizing false‐positive referral to the hospital eye service. Methods Expert panel structured discussions between 2000 and 2002 with review of existing evidence and grading classifications. Proposals Principles of the protocol include: separate grading of retinopathy and maculopathy, minimum number of steps, compatible with central monitoring, expandable for established more complex systems and for research, no lesion counting, no ‘questionable’ lesions, attempt to detect focal exudative, diffuse and ischaemic maculopathy and fast track referral from primary or secondary graders. Sight‐threatening diabetic retinopathy is defined as: preproliferative retinopathy or worse, sight‐threatening maculopathy and/or the presence of photocoagulation. In the centrally reported minimum data set retinopathy is graded into four levels: none (R0), background (R1), preproliferative (R2), proliferative (R3). Maculopathy and photocoagulation are graded as absent (M0, P0) or present (M1, P1). Discussion The protocol developed by the Diabetic Retinopathy Grading and Disease Management Working Party represents a new consensus upon which national guidelines can be based leading to the introduction of quality‐assured screening for people with diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2003.01077.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 200

Metadata

Authors
Harding, S., Greenwood, R., Aldington, S., Gibson, J., Owens, D., Taylor, R., Kohner, E., Scanlon, P., Leese, G., & Party, T. D. R. G. A. D. M. W.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2003-11-24
Volume
20
Issue
12
Pages
965-971
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2039248126
Cited by
200
References
0
FWCI
5.13
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Grading and disease management in national screening for diabetic retinopathy in England and Wales. https://app.cochat.ai/papers/10.1111/j.1464-5491.2003.01077.x
The paper
Harding, S., Greenwood, R., Aldington, S., Gibson, J., Owens, D., Taylor, R., Kohner, E., Scanlon, P., Leese, G., & Party, T. D. R. G. A. D. M. W. (2003). Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2003.01077.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.